Avadel Pharmaceuticals plc (AVDL) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | 23.26M | 12.7M | -8.23M | 7.87M | -6.89M | -18.19M | -29.7M | -28.03M | -38.23M | -32.02M | -30.23M | -15.37M |
| Operating CF Margin % | 30.03% | 18.64% | -15.68% | 15.62% | -13.77% | -43.82% | -109.29% | -144.09% | -545% | -2140.57% | - | - |
| Operating CF Growth % | 437.59% | 169.82% | 72.29% | 128.09% | 81.98% | 43.21% | 1.75% | -82.41% | -461.9% | -127.27% | 11.2% | 31.72% |
| Net Income | 20K | 9.66M | -4.92M | -5.04M | -2.63M | -13.82M | -27.34M | -28.79M | -36.27M | -64.43M | -30.78M | -27.45M |
| Depreciation & Amortization | 1.11M | 1.07M | 825K | 668K | 1.03M | 437K | 541K | -18K | 595K | 601K | 588K | 586K |
| Stock-Based Compensation | 0 | 5.33M | 4.18M | 4.13M | 5.41M | 5.46M | 5.39M | 3.52M | 3.13M | 7.64M | 1.52M | 1.93M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -15.94M | 0 | 0 | 0 | 109K |
| Other Non-Cash Items | 25.96M | -856K | 70K | 224K | 156K | -489K | -719K | 17.55M | -55K | 13.76M | 1.87M | 2.44M |
| Working Capital Changes | -3.83M | -2.51M | -8.39M | 7.9M | -10.87M | -9.77M | -7.57M | -4.35M | -5.62M | 10.4M | -3.43M | 7.02M |
| Change in Receivables | -1.94M | 950K | -7.48M | 3M | -3.73M | -10.69M | -10.59M | -5.9M | -6.59M | 352K | 0 | 3K |
| Change in Inventory | -737.28K | -3.29M | -66K | -3.96M | -2.99M | -1M | -1.26M | -4.25M | -3.85M | -1.44M | 0 | -3K |
| Change in Payables | 2.41M | 999K | 1.78M | -577K | -1.88M | -9.17M | 7.53M | -2.29M | 1.37M | 2M | 468K | 8.52M |
| Cash from Investing | -8.79M | -8.25M | 12.32M | 14.91M | 4.93M | 10.55M | 21.39M | 27.93M | 9.82M | -92.91M | 5.07M | 22.88M |
| Capital Expenditures | -10.76K | -181K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -716K |
| CapEx % of Revenue | 0.01% | 0.27% | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -15.69M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 716K |
| Cash from Financing | 2.63M | 982K | 690K | 880K | 1.18M | 723K | 13.19M | -21.11M | 30.46M | 91.54M | 34.44M | 6.62M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -21.16M | 0 | 0 | -17.5M | 0 |
| Equity Issued (Net) | 1000K | 1000K | 690K | 0 | 0 | 0 | 1000K | 2K | -2K | 1000K | 1000K | 1000K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | -64.51K | 0 | 880K | 1.18M | 723K | 3.94M | 52K | 30.46M | -42.61M | 29K | -8.16M |
| Net Change in Cash | 16.41M | 7.03M | 5M | 22.79M | -265K | -6.95M | 4.63M | -20.64M | 1.83M | -33.41M | 9.41M | 13.27M |
| Free Cash Flow | 23.25M | 12.52M | -8.23M | 7.87M | -6.89M | -18.19M | -29.7M | -28.03M | -38.23M | -32.02M | -30.23M | -16.08M |
| FCF Margin % | 30.01% | 18.37% | -15.68% | 15.62% | -13.77% | -43.82% | -109.29% | -144.09% | -545% | -2140.57% | - | - |
| FCF Growth % | 437.43% | 168.82% | 72.29% | 128.09% | 81.98% | 43.21% | 1.75% | -74.29% | -408.39% | -127.27% | 11.2% | 28.54% |
| FCF per Share | 0.23 | 0.13 | -0.09 | 0.08 | -0.07 | -0.19 | -0.32 | -0.33 | -0.43 | -0.41 | -0.47 | -0.25 |
| FCF Conversion (FCF/Net Income) | 1162.99x | 1.31x | 1.67x | -1.56x | 2.62x | 1.32x | 1.09x | 0.97x | 1.05x | 0.50x | 0.98x | 0.56x |
| Interest Paid | 0 | 1.97M | 0 | 3.88M | 1.56M | 1.02M | 730K | 0 | 0 | 1.47M | 3.05M | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |